Co-Authors
This is a "connection" page, showing publications co-authored by MAYAR AL MOHAJER and TODD LASCO.
Connection Strength
7.598
-
Enhanced C. auris screening and rapid diagnostics in cluster units: association with fewer incident clinical cases. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e105.
Score: 0.986
-
Comparative diagnostic performance of plasma microbial cell-free DNA sequencing versus amplicon-based blood next-generation sequencing in suspected bloodstream or endovascular infection: a single-center study. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e69.
Score: 0.977
-
The Impact of Initial Specimen Diversion Systems on Blood Culture Contamination. Open Forum Infect Dis. 2023 May; 10(5):ofad182.
Score: 0.795
-
Plasma microbial cell-free DNA sequencing for detection of Coxiella burnetii aortic endograft infection with vertebral osteomyelitis. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e203.
Score: 0.249
-
Emergency department urine culture stewardship and downstream outcomes: a covariate-adjusted biweekly interrupted time series analysis. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e196.
Score: 0.249
-
Mindful diagnostics in culture-negative endocarditis: early noninvasive diagnosis of Tropheryma whipplei by plasma microbial cell-free DNA. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e179.
Score: 0.248
-
Candida auris screening positivity after discontinuation of cohort units and enhanced nursing engagement: An interrupted time series. Am J Infect Control. 2026 Jun 04.
Score: 0.247
-
Diagnosis of histoplasmosis by next-generation sequencing of microbial cell-free DNA in Texas. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e164.
Score: 0.247
-
Clinical utility of plasma microbial cell-free DNA sequencing for early diagnosis of toxoplasmosis in high-risk patients: a five-patient case series. Antimicrob Steward Healthc Epidemiol. 2026; 6(1):e134.
Score: 0.246
-
Clinical impact of microbial cell-free DNA next-generation sequencing for invasive mold infection-a single-center retrospective observational study. Ther Adv Infect Dis. 2026 Jan-Dec; 13:20499361261437009.
Score: 0.244
-
Comparing the effects of commercial to open initial specimen diversion techniques on clinical outcomes and institutional costs. Infect Control Hosp Epidemiol. 2026 Feb 26; 1-4.
Score: 0.243
-
Utility of microbial cell-free DNA sequencing in the diagnosis of mycobacterial infections in a quaternary care center. Antimicrob Steward Healthc Epidemiol. 2025; 5(1):e160.
Score: 0.233
-
Impact of a cerebrospinal fluid diagnostic stewardship intervention on quantity of tests, length of stay, antibiotic prescriptions, and cost. Antimicrob Steward Healthc Epidemiol. 2025; 5(1):e35.
Score: 0.226
-
The utilization of microbial cell-free DNA next-generation sequencing for the detection of human herpesvirus-8 in a quaternary care center. Ther Adv Infect Dis. 2025 Jan-Dec; 12:20499361251313832.
Score: 0.225
-
Comparing the effects of two initial specimen diversion techniques on blood culture contamination rates and clinical outcomes-a multicenter study. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e194.
Score: 0.222
-
The impact of the FilmArray meningitis/encephalitis panel on empiric antibiotic prescriptions in patients with suspected community-acquired meningitis. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e104.
Score: 0.217
-
The impact of direct inoculation of ascites into blood culture bottles on ascites culture positivity. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e85.
Score: 0.215
-
Detection of invasive Bartonella infections with next-generation sequencing of microbial cell-free DNA. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e20.
Score: 0.211
-
The impact of a blood-culture diagnostic stewardship intervention on utilization rates and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2024 05; 45(5):670-673.
Score: 0.208
-
Discontinuation of contact precautions in patients with hospital-acquired MRSA and VRE infections during the COVID-19 pandemic: A multi-center experience. J Infect Prev. 2024 Mar; 25(1-2):33-37.
Score: 0.206
-
Impact of gastrointestinal polymerase chain reaction panels on antibiotic utilization in hospitalized adult patients. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e135.
Score: 0.203
-
The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective study. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e31.
Score: 0.197
-
Characteristics of Rickettsia typhi Infections Detected with Next-Generation Sequencing of Microbial Cell-Free Deoxyribonucleic Acid in a Tertiary Care Hospital. Open Forum Infect Dis. 2021 Jul; 8(7):ofab147.
Score: 0.173
-
Association between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients. Int J Infect Dis. 2021 Apr; 105:252-255.
Score: 0.171
-
Using clinical decision support to improve urine culture diagnostic stewardship, antimicrobial stewardship, and financial cost: A multicenter experience. Infect Control Hosp Epidemiol. 2020 05; 41(5):564-570.
Score: 0.160